Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : firstname.lastname@example.org
Amcasertib (BBI503) is a kinase inhibitor that inhibits signaling pathways that regulate survival of cancer stem cells, resulting in decreased cancer cell growth (NCI Drug Dictionary).
|CAS Registry Number||1129403-56-0|
|Therapy Name||Drugs||Efficacy Evidence||Clinical Trials|
|Amcasertib + Sorafenib||Amcasertib Sorafenib||0||1|